MENU
CGON
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CG Oncology (CGON) Ownership - Who owns CG Oncology?

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more

Profile

Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.98B
P/E Ratio
N/A
Total Cash
688.43M
Projected Growth
N/A
Total Debt
1.04M
Revenue
662K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.03
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

CGON
Capitalization
1.98B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
688M
Total Cash/Share
9.03
Total Debt
1.04M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
662K
ROE
N/A
Book Value
705M
P/B Ratio
2.81
Cash Flow
N/A
Earnings
-1.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
30.97
Current Revenue Per Employee
460.18
Dividends Per Share - Security
N/A
EBITDA
-134.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-16.15
Shares Held By Institutions
2.45B
Shares Outstanding - Current
76.2M
Total Liabilities
23.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.519
View a ticker or compare two or three
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com